ClinicalTrials.gov
public full text
Public Domain
Caffeic Acid Combining High-dose Dexamethasone in Management of ITP
The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of caffeic acid tablets combining with high-dose dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Immune Thrombocytopenia (ITP) Immune-Genetic Assessment#1151314
- The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP#980306
- A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP#1074133
- Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent Tuberculosis#868134
- Immune Markers in Pediatric ITP on Second Line Therapy#843940
Record · ID 885340
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive